UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026313
Receipt number R000030220
Scientific Title A clinical study on conjunctival malignant melanoma
Date of disclosure of the study information 2017/03/31
Last modified on 2018/02/27 13:51:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A clinical study on conjunctival malignant melanoma

Acronym

A clinical study on conjunctival malignant melanoma

Scientific Title

A clinical study on conjunctival malignant melanoma

Scientific Title:Acronym

A clinical study on conjunctival malignant melanoma

Region

Japan


Condition

Condition

Conjunctival malignant melanoma

Classification by specialty

Ophthalmology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to analyze clinical course, contents of treatments and distant metastasis in biopsy-proven conjunctival melanoma.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Contents of treatments, presence of distant metastasis one month, 6, 12, 24, 36 months after initial presentation

Key secondary outcomes

if globe was preserved, changing of slit-lamp examination findings


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Biopsy-proven conjunctival melanoma cases

Key exclusion criteria

Conjunctival nevus/melanosis

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satoru Kase

Organization

Hokkaido University

Division name

Ophthalmology

Zip code


Address

Sapporo city, N14 W5

TEL

011-706-5944

Email

kaseron@med.hokudai.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Satoru Kase

Organization

Hokkaido University

Division name

Ophthalmology

Zip code


Address

Sapporo city, N14 W5

TEL

011-706-5944

Homepage URL


Email

kaseron@med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University

Institute

Department

Personal name



Funding Source

Organization

Hokkaido University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

one patient developed distant metastasis

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 11 Month 08 Day

Date of IRB


Anticipated trial start date

2016 Year 11 Month 09 Day

Last follow-up date

2018 Year 02 Month 22 Day

Date of closure to data entry

2018 Year 02 Month 22 Day

Date trial data considered complete

2018 Year 02 Month 28 Day

Date analysis concluded

2018 Year 03 Month 01 Day


Other

Other related information

5 biopsy-proven conjunctival melanoma cases are enrolled


Management information

Registered date

2017 Year 02 Month 26 Day

Last modified on

2018 Year 02 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030220


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name